Investor and operating executive with experience in growth-stage technology, SaaS go-to-market and corporate development across venture and private equity-backed businesses. Kristy DeJarnette brings leadership in scaling sales, partnerships and M&A execution, having led commercial strategy and investor relations roles and advised multiple startups on capital raises. Market-relevant strengths include revenue operations, board-level governance and sector-focused deal sourcing.
Investor and operating executive with experience in growth-stage technology, SaaS go-to-market and corporate development across venture and private equity-backed businesses. Kristy DeJarnette brings leadership in scaling sales, partnerships and M&A execution, having led commercial strategy and investor relations roles and advised multiple startups on capital raises. Market-relevant strengths include revenue operations, board-level governance and sector-focused deal sourcing.
Targets growth-stage technology and SaaS businesses where commercial scaling can unlock value. Prefers revenue-first KPIs, repeatable GTM motions and capital-efficient expansion; invests with a 3–7 year horizon balancing growth capture and path-to-profitability. Underwrites deals through customer traction, unit economics and founder/operator alignment, brings active capital via go-to-market playbooks, board governance and M&A optionality. Risk-managed through staged commitments, milestone-based funding and emphasis on partnership-led distribution.
Targets growth-stage technology and SaaS businesses where commercial scaling can unlock value. Prefers revenue-first KPIs, repeatable GTM motions and capital-efficient expansion; invests with a 3–7 year horizon balancing growth capture and path-to-profitability. Underwrites deals through customer traction, unit economics and founder/operator alignment, brings active capital via go-to-market playbooks, board governance and M&A optionality. Risk-managed through staged commitments, milestone-based funding and emphasis on partnership-led distribution.
| Trades 1411 | Longs Won 1069/1411 75% | Profit Factor 15.64 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.13M |
| Average Win $185,883.86 | Best Trade (Mar 31) $27.14M | Sharpe Ratio -10.61 |
| Average Loss -$37,159.03 | Worst Trade (Oct 14) -$6.4M | Z-Score 13.51 (100%) |
| Commissions $0 | Avg. Trade Length 1y 5m 3w 1d | Expectancy $130,754.87 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 16,667 | 15,000 | 13,333 | 11,667 | 10,000 | 8,333 | 6,667 | 5,000 | 3,333 | 1,667 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 9170 91703D100 | 13,052 | $36,285 | $36,285 | - | - | - | 0.0 |
AAPL Apple Inc. | 50,932 | $8.81M | $17.56M | - | $8.75M | 99.25% | +0.788% |
ABBV AbbVie Inc. | 3,178 | $486,374.89 | $906,794.63 | - | $420,419.74 | 86.44% | +0.683% |
ABT Abbott Laboratories | 3,679 | $358,811.67 | $386,552.53 | - | $27,740.86 | 7.73% | +0.373% |
AEM Agnico Eagle Mines Limited | 1,311 | $220,982.01 | $251,567.79 | - | $30,585.78 | 13.84% | +2.309% |
ALNY Alnylam Pharmaceuticals Inc | 750 | $225,773 | $176,632.5 | - | -$49,140.5 | -21.77% | +0.632% |
AMAT Applied Materials, Inc. | 537 | $388,459 | $226,098.48 | - | -$162,360.52 | -41.8% | -2.086% |
AMD Advanced Micro Devices, Inc. | 6,426 | $1.41M | $3.5M | - | $2.09M | 147.91% | -3.223% |
AMGN Amgen Inc. | 1,352 | $364,519.81 | $590,567.12 | - | $226,047.31 | 62.01% | +0.641% |
AMZN Amazon.com Inc | 26,181 | $4.34M | $6.63M | - | $2.3M | 52.98% | -0.55% |
ANET Arista Networks, Inc. | 5,204 | $609,587.64 | $947,414.17 | - | $337,826.53 | 55.42% | -1.899% |
APH Amphenol Corporation | 10,792 | $397,083.11 | $873,504.48 | - | $476,421.37 | 119.98% | -0.675% |
AROC Archrock Inc. | 12,150 | $304,806.26 | $359,640 | - | $54,833.74 | 17.99% | +1.197% |
ASML ASML Holding N.V. New York Registry Shares | 255 | $378,933.67 | $426,484.95 | - | $47,551.28 | 12.55% | +0.908% |
AVGO Broadcom Inc. | 6,073 | $891,119.02 | $2.05M | - | $1.16M | 129.91% | -2.026% |
AXP American Express Company | 7,488 | $1.12M | $2.39M | - | $1.27M | 113.45% | +1.552% |
BABA Alibaba Group Holding Limited SP ADR | 4,018 | $360,053.24 | $446,439.98 | - | $86,386.74 | 23.99% | -0.018% |
BAC Bank of America Corporation | 9,290 | $281,332 | $488,700.45 | - | $207,368.45 | 73.71% | +1.75% |
BN Brookfield Corporation | 7,451 | $199,291.9 | $275,016.41 | - | $75,724.51 | 38% | +0.272% |
BRK-B Berkshire Hathaway Inc. | 37,960 | $13.47M | $20.18M | - | $6.72M | 49.89% | +1.152% |